Carbamazepine CLIA Kit


Product Name: Carbamazepine CLIA Kit (Chemiluminescence Immunoassay) Abbreviation: Carb


Carbamazepine CLIA Kit (Chemiluminescence Immunoassay) is an in vitro diagnostic test for the quantitative detection of Carbamazepine (Carb) in human serum and plasma specimen. This product is intended to be used by laboratory professional workers only. This kit is used for auxiliary diagnosis. Results must be combined with clinical observations, patient history, other laboratory parameters, and epidemiological information. Carbamazepine is a commonly used clinical anti-epileptic drug, but it has the characteristics of narrow therapeutic window, large individual differences, and long medication cycle. Therefore, monitoring its blood drug concentration has become an important reference for adjusting dose, evaluating side effects, and ensuring curative effect. In the process of treating children with epilepsy, it is necessary to customize an individualized dosing plan based on the children’s own factors, and monitor the blood drug concentration to improve the safety and effectiveness of the drug